Cardiovascular Frailty
Current understanding
Cardiovascular frailty is a proposed phenotype that integrates blood-pressure dynamics (orthostatic and diurnal variability), vascular ageing (arterial stiffness, endothelial dysfunction), and oxi-inflammaging into a single clinical construct that bidirectionally links frailty with cardiovascular morbidity and mortality [expert-opinion]. The framing is drawn from narrative synthesis of existing frailty and vascular-ageing literature rather than a validated instrument or outcome study [expert-opinion]. Human-translation status: no dedicated diagnostic criteria, prospective cohort validation, or intervention trial yet distinguishes cardiovascular frailty from Fried physical frailty or the cardiovascular-disease + frailty overlap already captured by existing scales.
Evidence log
- 2026-08-29 — Peripheral blood mitochondrial DNA copy number is associated with cardiac diastolic dysfunction in frail older adults.: cross-connection with mitochondrial-dysfunction: Human observational evidence [human-observational] links lower peripheral blood mtDNA copy number to diastolic dysfunction most strongly in frail older adults, identifying frailty as a reported modifier of the association rather than establishing a causal mitochondrial pathway. (novelty: 3)
- 2026-07-11 — Chronic subdural hematoma as failed resolution at the aged dura-subdural interface: Immune-vascular mechanisms, biomarker interpretation, and therapeutic translation.: cross-connection with chronic-subdural-hematoma-geroscience: Review integrates frailty (including vascular-frailty constructs) as a determinant of local hematoma non-resolution, linking CSDH biology to the frailty-as-phenotype literature rather than treating it as an isolated neurosurgical outcome. (novelty: 3)
- 2026-09-28 — The effect of pectin supplementation on geriatric individuals with frailty: a randomised placebo-controlled dietary intervention study.: cross-connection with gut-microbiota-healthspan: LM pectin RCT in frail older adults links a microbiota-targeted fibre intervention to functional frailty metrics (30-s sit-to-stand), connecting the microbiota-healthspan page to the frailty mechanism node via a human trial. (novelty: 3)
- 2026-09-18 — Frailty of older patients is not reflected in the melanoma tumor microenvironment and treatment response to immune checkpoint blockade therapy.: cross-connection with immunosenescence: Melanoma-ICB study provides a concrete example where clinical frailty (the phenotype cardiovascular-frailty formalizes) dissociates from a tissue-local immune-aging readout — frailty is not a uniform proxy for local immune dysfunction. (novelty: 3)
- 2026-09-25 — Longitudinal proteomic organ-specific aging in heart failure.: cross-connection with immunosenescence: Immune organ proteomic age gap predicts HF adverse events independently of NT-proBNP/troponin T, tying immunosenescence quantification directly to a cardiovascular-frailty-adjacent prognostic axis. (novelty: 4)